Paroxetine versus other anti-depressive agents for depression

Paroxetine versus other anti-depressive agents for depression

Podrobná bibliografie
Hlavní autoři:	Purgato, M, Papola, D, Gastaldon, C, Trespidi, C, Magni, L, Rizzo, C, Furukawa, T, Watanabe, N, Cipriani, A, Barbui, C
Médium:	Journal article
Vydáno:	2014

Podobné jednotky

Fluoxetine versus other types of pharmacotherapy for depression
Autor: Magni, L, a další
Vydáno: (2013)

Citalopram versus other anti-depressive agents for depression.
Autor: Cipriani, A, a další
Vydáno: (2012)

Duloxetine versus other anti-depressive agents for depression.
Autor: Cipriani, A, a další
Vydáno: (2012)

Fluvoxamine versus other anti-depressive agents for depression.
Autor: Omori, I, a další
Vydáno: (2010)

Mirtazapine versus other antidepressive agents for depression.
Autor: Watanabe, N, a další
Vydáno: (2011)

Milnacipran versus other antidepressive agents for depression.
Autor: Nakagawa, A, a další
Vydáno: (2009)

Escitalopram versus other antidepressive agents for depression.
Autor: Cipriani, A, a další
Vydáno: (2009)

Sertraline versus other antidepressive agents for depression.
Autor: Cipriani, A, a další
Vydáno: (2009)

Sertraline versus other antidepressive agents for depression.
Autor: Cipriani, A, a další
Vydáno: (2010)

Sertraline versus other antidepressive agents for depression
Autor: Cipriani, A, a další
Vydáno: (2010)

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.
Autor: Barbui, C, a další
Vydáno: (2008)

Fluoxetine versus other types of pharmacotherapy for depression
Autor: Cipriani, A, a další
Vydáno: (2009)

Fluoxetine versus other types of pharmacotherapy for depression.
Autor: Cipriani, A, a další
Vydáno: (2005)

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
Autor: Watanabe, N, a další
Vydáno: (2008)

Brexpiprazole versus placebo or other antidepressive agents for treating depression
Autor: Ralovska, S, a další
Vydáno: (2021)

Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders
Autor: D. Papola, a další
Vydáno: (2024-04-01)

Safety of psychotropic medications in people with COVID-19
Autor: G. Ostuzzi, a další
Vydáno: (2021-04-01)

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
Autor: Nakagawa, A, a další
Vydáno: (2008)

Long-term treatment of depression with antidepressants: a systematic narrative review.
Autor: Furukawa, T, a další
Vydáno: (2007)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
Autor: Kishi T, a další
Vydáno: (2017-01-01)

Depressive disorder needs an evidence base commensurate with its public health importance.
Autor: Geddes, J, a další
Vydáno: (2007)

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
Autor: Chen JW, a další
Vydáno: (2018-02-01)

Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression.
Autor: Benjamin D Schalet, a další
Vydáno: (2016-01-01)

Which psychotherapy is effective in panic disorder? Findings and reflections from a systematic network meta-analysis
Autor: D. Papola, a další
Vydáno: (2021-04-01)

Venlafaxine for major depression.
Autor: Cipriani, A, a další
Vydáno: (2007)

Suicide, depression, and antidepressants.
Autor: Cipriani, A, a další
Vydáno: (2005)

Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.
Autor: Cipriani, A, a další
Vydáno: (2007)

Novel melatonin-based treatments for major depression.
Autor: Barbui, C, a další
Vydáno: (2012)

Comparative efficacy and acceptability of psychosocial interventions for PTSD, depression, and anxiety in asylum seekers, refugees, and other migrant populations: a systematic review and network meta-analysis of randomised controlled studiesResearch in context
Autor: Giulia Turrini, a další
Vydáno: (2025-01-01)

Paroxetine treatment in an animal model of depression improves sperm quality
Autor: Reyhane Aghajani, a další
Vydáno: (2022-01-01)

Paroxetine treatment in an animal model of depression improves sperm quality.
Autor: Reyhane Aghajani, a další
Vydáno: (2022-01-01)

Why it is important to include unpublished data in systematic reviews.
Autor: Trespidi, C, a další
Vydáno: (2011)

Benzodiazepines and risk of dementia: true association or reverse causation?
Autor: Barbui, C, a další
Vydáno: (2013)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
Autor: Aoki A, a další
Vydáno: (2014-09-01)

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
Autor: Watanabe, N, a další
Vydáno: (2010)

Alpha oscillations predict paroxetine response to low sexual desire in depression
Autor: Mehmet Kemal Arıkan, a další
Vydáno: (2021-12-01)

Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine
Autor: Lijun Ning, a další
Vydáno: (2023-02-01)

Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.
Autor: Omori, I, a další
Vydáno: (2009)

No interaction between plasma IL-6 and MHPG in major depression treated with paroxetine
Autor: Reiji Yoshimura, a další
Vydáno: (2022-09-01)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
Autor: Kamijima K, a další
Vydáno: (2013-04-01)